These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4049764)

  • 41. [Optimum therapy of insulin-dependent diabetes mellitus].
    Sinagra D
    Recenti Prog Med; 1984 Sep; 75(9):823-32. PubMed ID: 6393244
    [No Abstract]   [Full Text] [Related]  

  • 42. Glucose monitoring and pump data management software operated on a personal digital assistant can contribute to improve diabetes control in CSII-treated patients.
    Boizel R; Benhamou PY; Renard E;
    Diabetes Metab; 2007 Sep; 33(4):314-5. PubMed ID: 17475533
    [No Abstract]   [Full Text] [Related]  

  • 43. Human insulin and insulin pumps.
    Shuman CR
    Clin Ther; 1984; 6(4):380-7. PubMed ID: 6380721
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy of insulin-dependent diabetes mellitus].
    Fink RR
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):96-9. PubMed ID: 6402679
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of the biostator (artificial pancreas) in the treatment of patients with diabetes mellitus].
    Spesivtseva VG; Mamaeva GG; Belokrinitskiĭ DV; Starosel'tseva LK; Turova EA
    Klin Med (Mosk); 1984 Oct; 62(10):55-60. PubMed ID: 6513454
    [No Abstract]   [Full Text] [Related]  

  • 46. Diurnal pattern of insulin requirements in insulin-dependent diabetics.
    Mathiesen ER; Rubin P; Sandahl Christiansen J; Aaby Svendsen P; Lauritzen T; Deckert T
    Scand J Clin Lab Invest; 1982 Feb; 42(1):63-8. PubMed ID: 6753093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
    Ratzmann KP; Jutzi E; Albrecht G
    Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of an artificial beta cell based on telemetry].
    Wilke W; Detschew W; Kasch J; Rebrin K; von Woedtke T; Abel P
    Biomed Tech (Berl); 1990; 35 Suppl 3():228-9. PubMed ID: 2078707
    [No Abstract]   [Full Text] [Related]  

  • 49. [Insulin therapy with pens and pumps].
    Schwedes U
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of the endocrine artificial pancreas (GCIIS; Biostator) in heart surgery].
    Calabrese G; Bueti A; Zega G; Bellomo G; Antonella MA; Giombolini A; Tardioli F; Massi-Benedetti M; Palminiello A
    Minerva Med; 1982 Dec; 73(49-50):3509-14. PubMed ID: 7155400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are you ready for the pump? The decision to use an insulin pump is a serious one. Here are a few questions to consider first.
    Ahern JA
    Diabetes Forecast; 2002 Nov; 55(11):60-2. PubMed ID: 14768606
    [No Abstract]   [Full Text] [Related]  

  • 52. Insulin pumps: choice and management.
    De Nobel E
    Neth J Med; 1984; 27(5):193-5. PubMed ID: 6728082
    [No Abstract]   [Full Text] [Related]  

  • 53. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control.
    Feldt-Rasmussen B
    Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466
    [No Abstract]   [Full Text] [Related]  

  • 54. [Improved metabolic control, kidney function and health care economics are the results of treatment with insulin pump].
    Johansson BL; Berg U; Broberger O; Thalme B
    Lakartidningen; 1983 Oct; 80(41):3818-20. PubMed ID: 6645721
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experience in the use of biostator in the treatment of diabetes mellitus in children of the pubertal age].
    Antsiferov MB; Karpova LA; Kolesnikova GS; Pankova SS; Starostina EG
    Pediatriia; 1989; (11):18-22. PubMed ID: 2608369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics.
    Coppola L; Misso L; Giugliano D; Torella R; Passariello N; Tirelli A
    Diabete Metab; 1984 Jan; 10(1):31-5. PubMed ID: 6724099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biostator education for staff development.
    Jacobson B
    Diabetes Educ; 1984; 10(2):26-30. PubMed ID: 6564951
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Feed-back control of blood glucose--present status and future of artificial endocrine pancreas].
    Shichiri M; Kawamori T
    Horumon To Rinsho; 1982 Sep; 30(9):953-7. PubMed ID: 7151293
    [No Abstract]   [Full Text] [Related]  

  • 60. [Combined use of automatic systems for treating patients with type 1 diabetes mellitus].
    Perelygina AA; Antsiferov MB; Starostina EG
    Probl Endokrinol (Mosk); 1987; 33(5):3-6. PubMed ID: 3422932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.